Spectramin BPH, Smoking Deterrent Claims Cited In FDA Warning Letter
This article was originally published in The Tan Sheet
Prostate disorder relief claims for Spectramin's Ultra Prost-Aide 2000 supplement product are disease claims, FDA says in a Nov. 20 warning letter to the Sunrise, Fla.-based dietary supplement marketer.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC